<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02588430</url>
  </required_header>
  <id_info>
    <org_study_id>RI-PMCF1-EU</org_study_id>
    <nct_id>NCT02588430</nct_id>
  </id_info>
  <brief_title>PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS</brief_title>
  <official_title>Post-Market Clinical Follow-up Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Retina Implant AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Retina Implant AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a post-market clinical follow-up (PMCF) study to monitor the safety, lifetime
      and efficacy of patients using the CE-certified RETINA IMPLANT Alpha AMS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a post-market clinical follow-up (PMCF) study to monitor the safety, lifetime
      and efficacy of patients using the CE-certified RETINA IMPLANT Alpha AMS. For Germany, it is
      under the exceptions mentioned in §23b MPG (Medizinproduktegesetz, German Medical Device
      Law). Its purpose is to collect data that is created during the regular therapy with the
      implant. No additional examinations are performed, except a patient questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Manufacturer of the investigational device has ceased all business activities
  </why_stopped>
  <start_date type="Anticipated">March 2019</start_date>
  <completion_date type="Anticipated">June 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2029</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Years</target_duration>
  <primary_outcome>
    <measure>Time to device failure</measure>
    <time_frame>6 Years</time_frame>
    <description>Recording of device failures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number, nature and severity of challenges or complications during surgical procedures</measure>
    <time_frame>6 Years</time_frame>
    <description>Recording of adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number, nature and severity of device-related adverse events and incidents until device failure or explantation</measure>
    <time_frame>6 Years</time_frame>
    <description>Recording of adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. Functional Vision Test</measure>
    <time_frame>6 Years</time_frame>
    <description>Eye-hand coordination: a cup should be placed in the middle of a plate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2. Functional Vision Test</measure>
    <time_frame>6 Years</time_frame>
    <description>Activity of daily living - Table test: 4 white items of big plate, small plate, bowl, cup and cutlery are placed on a black table cloth and should be identified and touched</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3. Functional Vision Test</measure>
    <time_frame>6 Years</time_frame>
    <description>Activity of daily living - Clothes sorting: socks in white, grey and black should be sorted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4. Functional Vision Tests</measure>
    <time_frame>6 Years</time_frame>
    <description>Assessment of grating acuity: cards with grid patterns of different widths are presented and should be described</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual related quality of life (Patient reported outcome)</measure>
    <time_frame>6 Years</time_frame>
    <description>Impact of Vision Impairment - Very Low Vision Questionnaire (IVI-VLV) (Finger et al., 2014) is asking for vision-related quality of life by rating impact of eyesight on various tasks, referring to the last month</description>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who received a Retina Implant Alpha at the study site. Patients who are fulfilling
        specific criteria to receive a RETINA IMPLANT Alpha AMS.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who received a RETINA IMPLANT Alpha AMS.

          -  Patients willing and able to give written informed consent.

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian Gekeler, Prof Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katharinenhospital Stuttgart</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Katharinenhospital Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Stingl K, Bartz-Schmidt KU, Besch D, Braun A, Bruckmann A, Gekeler F, Greppmaier U, Hipp S, Hörtdörfer G, Kernstock C, Koitschev A, Kusnyerik A, Sachs H, Schatz A, Stingl KT, Peters T, Wilhelm B, Zrenner E. Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc Biol Sci. 2013 Feb 20;280(1757):20130077. doi: 10.1098/rspb.2013.0077. Print 2013 Apr 22.</citation>
    <PMID>23427175</PMID>
  </reference>
  <reference>
    <citation>Koitschev A, Stingl K, Bartz-Schmidt KU, Braun A, Gekeler F, Greppmaier U, Sachs H, Peters T, Wilhelm B, Zrenner E, Besch D. Extraocular Surgical Approach for Placement of Subretinal Implants in Blind Patients: Lessons from Cochlear-Implants. J Ophthalmol. 2015;2015:842518. doi: 10.1155/2015/842518. Epub 2015 Dec 10.</citation>
    <PMID>26783453</PMID>
  </reference>
  <reference>
    <citation>Stingl K, Bartz-Schmidt KU, Besch D, Chee CK, Cottriall CL, Gekeler F, Groppe M, Jackson TL, MacLaren RE, Koitschev A, Kusnyerik A, Neffendorf J, Nemeth J, Naeem MA, Peters T, Ramsden JD, Sachs H, Simpson A, Singh MS, Wilhelm B, Wong D, Zrenner E. Subretinal Visual Implant Alpha IMS--Clinical trial interim report. Vision Res. 2015 Jun;111(Pt B):149-60. doi: 10.1016/j.visres.2015.03.001. Epub 2015 Mar 23.</citation>
    <PMID>25812924</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>September 30, 2014</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2015</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

